Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What have we learned from ICON1 and ACTION?

N Colombo1, S Pecorelli

  • 1European Institute of Oncology, Milan, Italy.

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|December 6, 2003
PubMed
Summary

Adjuvant platinum-containing chemotherapy significantly improves survival and reduces recurrence in early-stage ovarian cancer patients. This approach offers a survival benefit compared to observation alone after surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The MEATIC technique: Enhancing ureteral meatus visualization during pediatric cystoscopy using iodinated contrast.

Journal of pediatric urology·2026
Same author

Multimodal tumor-agnostic ctDNA analysis for minimal residual disease detection and risk stratification in ovarian cancer: results from the MITO16a/MaNGO-OV2 trial.

ESMO open·2026
Same author

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric survey.

ESMO open·2025
Same author

Reply by Authors.

The Journal of urology·2025
Same author

Predictive value of BRCA1/RAD51C methylation in HGSOC - An ancillary study of the PAOLA-1/ENGOT-ov25 phase 3 trial.

European journal of cancer (Oxford, England : 1990)·2025

Area of Science:

  • Gynecologic Oncology
  • Clinical Trials
  • Cancer Treatment

Background:

  • A significant percentage of early-stage ovarian cancer patients succumb to the disease.
  • The optimal adjuvant therapy following surgical staging remains debated, with no definitive survival advantage established for any approach over observation.

Purpose of the Study:

  • To evaluate the efficacy of platinum-containing adjuvant chemotherapy versus observation in patients with early-stage ovarian cancer.
  • To determine the impact of adjuvant chemotherapy on survival and recurrence rates.

Main Methods:

  • Combined analysis of two parallel randomized clinical trials (ICON 1 and ACTION) involving 924 patients.
  • Comparison of platinum-containing adjuvant chemotherapy against observation following surgical staging.
  • Primary endpoint: overall survival; Secondary endpoint: time to recurrence.

Main Results:

  • Adjuvant chemotherapy demonstrated a significant improvement in recurrence-free survival (hazard ratio 0.64, P = 0.001), with an 11% absolute difference.
  • Overall survival was also significantly improved with adjuvant chemotherapy (hazard ratio 0.67, P = 0.008), showing an 8% absolute difference.
  • Completeness of surgical staging was a key prognostic factor, and adjuvant chemotherapy improved outcomes in suboptimally staged patients.

Conclusions:

  • Adjuvant platinum-containing chemotherapy is a beneficial treatment for early-stage ovarian cancer, improving both disease-free and overall survival.
  • The findings support the use of adjuvant chemotherapy, particularly in patients who may not have had optimal surgical staging.

Related Experiment Videos